Look for:

Our offer for

FRESENIUS SE & CO. KGAA


ISIN:
DE0005785604
WKN:
578560
2021/04/16 17:35:29
Price
38.455 EUR
Difference 0.27% (0.11)

General attributes

ISINDE0005785604
SymbolFRE
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)21,222 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open38.35 EUR
High38.60 EUR
Low38.14 EUR
Close (prev. day)38.35 EUR
VWAP38.39101 EUR
Volume (pcs)1,315,120
Trading volume50,488,790.19
Number of trades6,618
Last size354,014

Futures and Options

Related Futures53
Related Options-

PDF Downloads

Annual report: FRESENIUS SE & CO. KGAAPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Erste Group related products on underlying

Product type # products
Reverse convertibles 1
Turbos 22
Express bonds 3

Recent research



2021/04/16 17:35:29
Price
38.455 EUR
Difference 0.27% (0.11)

General attributes

ISINDE0005785604
SymbolFRE
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)21,222 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open38.35 EUR
High38.60 EUR
Low38.14 EUR
Close (prev. day)38.35 EUR
VWAP38.39101 EUR
Volume (pcs)1,315,120
Trading volume50,488,790.19
Number of trades6,618
Last size354,014

Performance and Risk

6M1Y3Y
Perf (%)+5.27%+4.47%-39.82%
Perf (abs.)+1.93+1.65-25.45
Beta0.970.960.94
Volatility26.2130.1333.96
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)38.673 EUR (1,359,577)
Ø price 30 days | Ø volume 30 days (pcs.)37.215 EUR (1,570,740)
Ø price 100 days | Ø volume 100 days (pcs.)37.295 EUR (1,688,252)
Ø price 250 days | Ø volume 250 days (pcs.)39.034 EUR (1,830,586)
YTD High | date40.510 EUR (2021/01/07)
YTD Low | date32.940 EUR (2021/02/02)
52 Weeks High | date46.510 EUR (2020/06/24)
52 Weeks Low | date31.030 EUR (2020/10/30)

Erste Group related products on underlying

Product type # products
Reverse convertibles 1
Turbos 22
Express bonds 3

All listings for FRESENIUS SE & CO. KGAA

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/04/1617:3538.455 EUR50.496,618
Vienna Stock Exchange2021/04/1617:3238.52 EUR0.002
Tradegate2021/04/1622:2638.495 EUR4.18521
Stuttgart2021/04/1621:5538.45 EUR1.12207
SIX Swiss Exchange2020/04/0105:5553.06 CHF0.001
SIX Swiss Exchange2020/04/0117:3535.58 EUR0.001
Munich2021/04/1616:1138.44 EUR0.123
London Stock Exchange European Trade Reporting2021/04/1617:3038.52 EUR0.001
Hanover2021/04/1608:1038.49 EUR0.001
Hamburg2021/04/1617:1938.54 EUR0.077
Frankfurt2021/04/1618:1338.49 EUR0.0914
FINRA other OTC Issues2021/04/0916:4546.0585 USD0.011
Duesseldorf2021/04/1619:3138.41 EUR0.0119
Borsa Italiana MTF Global Equity Market2021/04/1617:3538.505 EUR0.011
Berlin2021/04/1618:4538.53 EUR0.0014

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=994&ID_TYPE_IMAGE_LOGO=2

Contact Details

FRESENIUS SE & CO. KGAA
- -
Else-Kröner-Strasse 1 - 61352 Bad Homburg
Telefon: 49-6172-608-0
Fax: 49-6172-608-2294
E-mail: pr-fre@fresenius.com

PDF Downloads

Annual report: FRESENIUS SE & CO. KGAAPDF Download

Company Profile

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises of dialysis products and healthcare services. The Fresenius Kabi segment specializes in intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Members of Management Board

Stephan SturmChairman of Managing Board
Ernst WastlerMember of Executive Committee
Francesco De MeoMember of Executive Committee
Jürgen GötzMember of Executive Committee
Markus GeorgiMember of Executive Committee
Rachel Clare EmpeyMember of Executive Committee
Rice PowellMember of Executive Committee

Board of directors

Gerd KrickChairman of Supervisory Board
Iris Löw-FriedrichMember of Supervisory Board
Michael AlbrechtMember of Supervisory Board
Bernd BehlertMember of Supervisory Board
Frauke LehmannMember of Supervisory Board
Hauke StarsMember of Supervisory Board
Klaus-Peter MüllerMember of Supervisory Board
Konrad KölblMember of Supervisory Board
Michael DiekmannMember of Supervisory Board
Niko StumpföggerMember of Supervisory Board
Oscar de PacoMember of Supervisory Board
Stefanie LangMember of Supervisory Board
Wolfgang KirschMember of Supervisory Board





Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.